Display options
Share it on
Full text links
HighWire Free PMC Article

Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11416-20. doi: 10.1073/pnas.88.24.11416.

TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia.

Proceedings of the National Academy of Sciences of the United States of America

Y Xia, L Brown, C Y Yang, J T Tsan, M J Siciliano, R Espinosa, M M Le Beau, R J Baer

Affiliations

  1. Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235.

PMID: 1763056 PMCID: PMC53146 DOI: 10.1073/pnas.88.24.11416
Free PMC Article

Abstract

Tumor-specific alteration of the TAL1 gene occurs in almost 25% of patients with T-cell acute lymphoblastic leukemia (T-ALL). We now report the identification of TAL2, a distinct gene that was isolated on the basis of its sequence homology with TAL1. The TAL2 gene is located 33 kilobase pairs from the chromosome 9 breakpoint of t(7;9)(q34;q32), a recurring translocation specifically associated with T-ALL. As a consequence of t(7;9)(q34;q32), TAL2 is juxtaposed with sequences from the T-cell receptor beta-chain gene on chromosome 7. TAL2 sequences are actively transcribed in SUP-T3, a T-ALL cell line that harbors the t(7;9)(q34;q32). The TAL2 gene product includes a helix-loop-helix protein dimerization and DNA binding domain that is especially homologous to those encoded by the TAL1 and LYL1 protooncogenes. Hence, TAL2, TAL1, and LYL1 constitute a discrete subgroup of helix-loop-helix proteins, each of which can potentially contribute to the development of T-ALL.

Similar articles

Cited by

Marotta P, Salatiello F, Ambrosino L, Berruto F, Chiusano ML, Locascio A.
Front Cell Dev Biol. 2021 Aug 03;9:709696. doi: 10.3389/fcell.2021.709696. eCollection 2021.
PMID: 34414189

References

  1. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9358-62 - PubMed
  2. Genes Chromosomes Cancer. 1990 Jan;1(3):194-208 - PubMed
  3. EMBO J. 1990 Oct;9(10):3343-51 - PubMed
  4. Am J Hum Genet. 1988 Aug;43(2):144-51 - PubMed
  5. Science. 1988 Jan 29;239(4839):487-91 - PubMed
  6. Proc Natl Acad Sci U S A. 1987 Jan;84(1):251-5 - PubMed
  7. Cell. 1987 Jul 3;50(1):107-17 - PubMed
  8. Blood. 1988 Feb;71(2):395-402 - PubMed
  9. J Exp Med. 1989 Feb 1;169(2):369-77 - PubMed
  10. Mol Cell Biol. 1989 May;9(5):2124-32 - PubMed
  11. Cell. 1989 Aug 11;58(3):537-44 - PubMed
  12. Cell. 1989 Mar 10;56(5):777-83 - PubMed
  13. FASEB J. 1989 Oct;3(12):2344-59 - PubMed
  14. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10128-32 - PubMed
  15. Cell. 1989 Jul 14;58(1):77-83 - PubMed
  16. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5039-43 - PubMed
  17. EMBO J. 1988 Feb;7(2):385-94 - PubMed
  18. Hum Genet. 1988 Nov;80(3):224-34 - PubMed
  19. Proc Natl Acad Sci U S A. 1986 May;83(10):3439-43 - PubMed
  20. Oncogene. 1990 Jul;5(7):1103-5 - PubMed
  21. Blood. 1990 Sep 15;76(6):1220-4 - PubMed
  22. J Exp Med. 1990 Feb 1;171(2):489-501 - PubMed
  23. EMBO J. 1990 Feb;9(2):415-24 - PubMed
  24. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4367-71 - PubMed
  25. Mol Cell Biol. 1991 Jun;11(6):3037-42 - PubMed
  26. Science. 1991 Mar 8;251(4998):1211-7 - PubMed
  27. Science. 1991 Feb 15;251(4995):761-6 - PubMed
  28. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8900-4 - PubMed
  29. Science. 1991 Jul 5;253(5015):79-82 - PubMed
  30. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5675-9 - PubMed
  31. J Clin Invest. 1991 Jun;87(6):2029-35 - PubMed
  32. Science. 1990 Dec 7;250(4986):1426-9 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources